However, there are natural limits to this method because tritium decay and dispersion make it increasingly difficult to identify the bomb peak in groundwater.These problems can be overcome by using tritium in combination with its decay product He age formally calculated from equation (1) is an apparent age.Our securities litigation practice has involved matters throughout the United States and abroad.In private civil cases, we have represented corporations, individuals or corporate committees in individual, derivative, and class action matters in every major commercial center in the country.In SEC investigations, we have represented clients in numerous informal and formal investigations, Wells submissions, and post-complaint lawsuits in federal courts across the country.We have also represented companies or shareholders in closely-held companies in contentious disputes over corporate management and control.We regularly represent parties in disputes involving corporate actions and securities matters, including both public companies as well as closely-held business organizations.
THIS SCORECARD WAS LAST UPDATED IN SEPTEMBER 2007 AND IS NO LONGER BEING UPDATED. Note: This list contains companies that have disclosed government probes, misdated options, restatements and/or executive departures as of Septmeber 2007.
As a result, it is possible that Activision will be required to record additional stock-based compensation expense related to stock-option grants.
On June 7, 2007, the company said the SEC issued a formal probe order related to its stock-options grants.
It is being examined by the Securities and Exchange Commission. 7, the company announced that investors should no longer rely on its prior disclosures about the findings of its continuing internal probe. Noncash compensation costs related to backdating will be about million, plus additional tax-related expenses.
It had previously said a preliminary review suggested no intentional backdating occurred and any charges were likely to be minor. (Headlines) (Options chart) The maker of gene-testing devices said on Aug 1 that an internal probe has uncovered "certain documentation lapses" in its stock options grant processes from 1997 through 1999, including one instance when the option grant date should have been recorded differently.
Investors initially pushed the stock up more than 1% but then pulled back slightly leaving it up 0.4% in after hours trading.